Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-01

Clinical Trial Update: In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children (MEFI_III) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating in vivo efficacy of artemether-lumefantrine and amodiaquine-artesunate for malaria in Mozambican children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amodiaquine + Artesunate
  • Artemether-lumefantrine (artemether and lumefantrine)

Snippet

Sponsor: Centro de Investigacao em Saude de Manhica | Conditions: Malaria | Phase 4 | Status: COMPLETED